Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stenting for Chronic Middle Cerebral Artery Occlusion
NCT06419283Phase 1Completed
- Sponsor
- Huizhou Central People's Hospital
- Start
- Aug 2019
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial in middle cerebral artery occlusion (MCAO) (2 arms), sponsored by Huizhou Central People's Hospital. Primary endpoints: Modified Rankin Scale at 3 months and National Institutes of Health Stroke Scale at 3 months. Started Aug 2019; status: completed.
02
Conditions
middle cerebral artery occlusion (MCAO)
Beyond the preview
Go deeper on NCT06419283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419283.